Nicola Muirhead

ORCID: 0000-0002-7430-1549
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Erythropoietin and Anemia Treatment
  • Prostate Cancer Diagnosis and Treatment
  • Parathyroid Disorders and Treatments
  • Pharmacological Effects and Toxicity Studies
  • Vitamin D Research Studies
  • Dialysis and Renal Disease Management
  • Prostate Cancer Treatment and Research
  • Sexual function and dysfunction studies
  • Microscopic Colitis
  • Chronic Kidney Disease and Diabetes
  • Radiomics and Machine Learning in Medical Imaging
  • Hemoglobinopathies and Related Disorders
  • Iron Metabolism and Disorders
  • Inflammatory Bowel Disease
  • Diabetes Treatment and Management
  • Ethics in Clinical Research
  • Patient-Provider Communication in Healthcare
  • Eicosanoids and Hypertension Pharmacology
  • Nutrition, Genetics, and Disease
  • Venous Thromboembolism Diagnosis and Management
  • Systemic Lupus Erythematosus Research
  • Blood Coagulation and Thrombosis Mechanisms
  • Blood transfusion and management
  • Muscle and Compartmental Disorders
  • Advanced MRI Techniques and Applications

University College London
2014-2023

Royal London Hospital
2023

Whipps Cross University Hospital
2023

Barts Health NHS Trust
2023

Royal Free London NHS Foundation Trust
2023

Mayo Clinic
2023

MRC Prion Unit
2022

Steno Diabetes Centers
2021

University of Copenhagen
2021

MRC Clinical Trials Unit at UCL
2014-2016

Rivaroxaban is established for the treatment and secondary prevention of venous thromboembolism, but whether it useful in patients with antiphospholipid syndrome uncertain.This randomised, controlled, open-label, phase 2/3, non-inferiority trial, done two UK hospitals, included who were taking warfarin previous a target international normalised ratio 2·5. Patients randomly assigned 1:1 to continue or receive 20 mg oral rivaroxaban daily. Randomisation was centrally, stratified by centre...

10.1016/s2352-3026(16)30079-5 article EN cc-by The Lancet Haematology 2016-08-26
Hiddo J.L. Heerspink C. David Sjöström Niels Jongs Glenn M. Chertow Mikhail Kosiborod and 95 more Fan Fan Hou John J.V. McMurray Peter Rossing Ricardo Correa‐Rotter Raisa Kurlyandskaya Bergur V. Stefánsson Robert D. Toto Anna Maria Langkilde David C. Wheeler Hiddo J.L. Heerspink David C. Wheeler Glenn M. Chertow Ricardo Correa‐Rotter Tom Greene Fan Fan Hou John J.V. McMurray Peter Rossing Robert D. Toto Bergur V. Stefánsson Anna Maria Langkilde Laura Maffei Pablo Raffaele S. Solís César A. Arias Dov Aizenberg Carolina Lúquez Cesar Javier Zaidman Natalia Cluigt M. Mayer A Alvarisqueta A. Wassermann Rafaël Maldonado J. Bittar M. Maurich L.E. Gaite Nicole Garcia Leonardo Sivak Pablo Ramallo Juan Carlos Santos Ruben Garcia Duran Juan Oddino A Marañón Lília Nigro Maia Dánae Duana Ávila Elvino Barros Maria H Vidotti Daniel Panarotto Irene de Lourdes Noronha Luiz Alberto Andreotti Turatti Luciane Mônica Deboni María Eugênia Fernandes Canziani Miguel C. Riella Marcelo Rodrigues Bacci Raphael Paschoalin R J Franco João Carlos Goldani Eric St-Amour Ann Steele Ronald Goldenberg S.B. Pandeya Harpreet S. Bajaj David Z.I. Cherney Stéphanie Kaiser James Conway Sharron Chow G.S. Bailey Jean‐Philippe Lafrance Jonathan Winterstein Serge Cournoyer Daniel Gaudet F. Madore Robyn L. Houlden Ashley Dowell Michel R. Langlois Nicola Muirhead Hasnain Khandwala Anna S. Levin Fan Fan Hou Ying Xue Zuo Li Chuan‐Ming Hao Zhaohui Ni Xing Changying N Chen Yugang Dong Rong Zhou Xiao Xu Yiping Zou Chu Wang Liu B Qian Chen Miao Lin Qin Luo David Zhang Jing Wang

Mortality rates from chronic kidney disease (CKD) have increased in the last decade. In this pre-specified analysis of DAPA-CKD trial, we determined effects dapagliflozin on cardiovascular and non-cardiovascular causes death.DAPA-CKD was an international, randomized, placebo-controlled trial with a median 2.4 years follow-up. Eligible participants were adult patients CKD, defined as urinary albumin-to-creatinine ratio (UACR) 200-5000 mg/g estimated glomerular filtration rate (eGFR) 25-75...

10.1093/eurheartj/ehab094 article EN cc-by-nc European Heart Journal 2021-02-09
Hiddo J.L. Heerspink David Z.I. Cherney Douwe Postmus Bergur V. Stefánsson Glenn M. Chertow and 95 more Jamie P. Dwyer Tom Greene Mikhail Kosiborod Anna Maria Langkilde John J.V. McMurray Ricardo Correa‐Rotter Peter Rossing C. David Sjöström Robert D. Toto David C. Wheeler Hiddo J.L. Heerspink David C. Wheeler Glenn M. Chertow Ricardo Correa‐Rotter Tom Greene Fan Fan Hou John J.V. McMurray Peter Rossing Robert D. Toto Bergur V. Stefánsson Anna Maria Langkilde Laura Maffei Pablo Raffaele S. Solís César A. Arias Dov Aizenberg Carolina Lúquez Cesar Javier Zaidman Natalia Cluigt M. Mayer Andres Alvarisqueta A. Wassermann Rafaël Maldonado J. Bittar M. Maurich L.E. Gaite Néstor H. García Louise E. Sivak Pablo Ramallo Juan Carlos Santos Ruben Garcia Duran Juan Oddino A Marañón Lília Nigro Maia Dánae Duana Ávila Elvino Barros Maria H Vidotti Daniel Panarotto Irene de Lourdes Noronha Luiz Alberto Andreotti Turatti Luciane Mônica Deboni María Eugênia Fernandes Canziani Miguel C. Riella Marcelo Rodrigues Bacci Raphael Paschoalin R J Franco João Carlos Goldani Eric St-Amour Andrew Steele R. Goldenberg Sanjay Pandeya Harpreet S. Bajaj David Z.I. Cherney Stéphanie Kaiser James Conway Sharron Chow G. Howard Bailey Jean‐Philippe Lafrance Jonathan Winterstein S. Cournoyer D. Gaudet F. Madore Robyn L. Houlden Aaron Dowell Michel R. Langlois Nicola Muirhead Hasnain Khandwala Adeera Levin Fan Fan Hou Ying Xue Lingyan Zuo Chuan‐Ming Hao Zhaohui Ni Xing Changying N. Chen Yugang Dong Rong Zhou Xiao Xu Yiping Zou Chu Wang Liu B Qian Chen Miao Lin Qing Luo D. Zhang

This pre-specified analysis of DAPA-CKD assessed the impact sodium-glucose cotransporter 2 inhibition on abrupt declines in kidney function high-risk patients based having chronic disease (CKD) and substantial albuminuria. was a randomized, double-blind, placebo-controlled trial that had median follow-up 2.4 years. Adults with CKD (urinary albumin-to-creatinine ratio 200–5000 mg/g estimated glomerular filtration rate 25–75 mL/min/1.73m2) were randomized to dapagliflozin 10 mg/day matched...

10.1016/j.kint.2021.09.005 article EN cc-by Kidney International 2021-09-22

Introduction Prostate MRI is a well-established tool for the diagnostic work-up men with suspected prostate cancer (PCa). Current recommendations advocate use of multiparametric (mpMRI), which composed three sequences: T2-weighted sequence (T2W), diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE). Prior studies suggest that biparametric (bpMRI) approach, omitting DCE sequences, may not compromise clinically significant detection, though there are limitations to these studies, it...

10.1136/bmjopen-2022-070280 article EN cc-by BMJ Open 2023-04-01
Francesco Giganti Alexander Ng Aqua Asif Vinson Wai‐Shun Chan Marimo Rossiter and 89 more Arjun Nathan Pramit Khetrapal Louise Dickinson Shonit Punwani Chris Brew‐Graves Alex Freeman Mark Emberton Caroline M. Moore Clare Allen Veeru Kasivisvanathan Adriano Basso Dias Aiman Haider Amara Khan Angela Tong Antti Rannikko Anu Kenttämies Ardeshir R. Rastinehad Armando Stabile Arnauld Villers Ash Tewari Aytekin Oto Bas Israël Byron Gaing Carmen Chi-Min Cho Carolina Aulló González Chau Hung Lee Christian Wetterauer Claudia Kesch Daniel A. Adamo Daniel Margolis Daniel José López Ruiz David Margel Declan G. Murphy Enrique Gómez‐Gómez Felix K.‐H. Chun Felix Preißer Francis Thomas Geert Villeirs Giancarlo Marra Gianluca Giannarini Giorgio Brembilla G. Robert Guglielmo Manenti Hannes Cash Ingrid Potyka Jan Philipp Radtke Jeffrey J. Leow Jens Theysohn Jim C. Hu Jingfei Ma Lance A. Mynderse Lars Boesen Lars Budäus Lars Schimmöller Lee Alexander Grant Luca Orecchia Maarten de Rooij Maneesh Ghei Marco Gatti Mariano Volpacchio Markku H. Vaarala Martina Pecoraro Massimo Imbriaco Matthias Roethke M.A. Rodríguez Cabello Nazar Miguel Paras Singh Nicola Muirhead Peter Ka‐Fung Chiu Philip Ryan Philippe Puech Pierre Mozer Pieter De Visschere Públio César Cavalcante Viana Raphaële Renard Penna Réka Novotta Renato Cuocolo Richard O’Sullivan Rossano Girometti Sangeet Ghai Scott E. Eggener Tharakeswara Bathala Tho Pham Tristan Barrett Valeria Panebianco Vibeke Løgager Vinayak Wagaskar Yaara Ber Y. Lebras

Background High variability in prostate MRI quality might reduce accuracy cancer detection. Purpose To prospectively evaluate the of scanners taking part control phase global PRIME (Prostate Imaging Using ± Contrast Enhancement) trial using Prostate Quality (PI-QUAL) standardized scoring system, give recommendations on how to improve protocols, and establish whether could be improved by these recommendations. Materials Methods In prospective clinical (PRIME), for each scanner, centers...

10.1148/radiol.231130 article EN Radiology 2023-10-01

This study examined the efficacy of C.E.R.A., a continuous erythropoietin receptor activator, for correcting anemia in patients who had chronic kidney disease (CKD) and were not on dialysis.In this open-label, randomized, parallel-group, Phase III study, 324 adult with CKD dialysis nor receiving treatment erythropoiesis-stimulating agents (ESAs) randomly assigned (1:1) to receive subcutaneous C.E.R.A. once every 2 wk or darbepoetin alfa weekly during an 18-wk correction period 10-wk...

10.2215/cjn.00480107 article EN Clinical Journal of the American Society of Nephrology 2008-02-21

Introduction The current mainstay of the treatment thrombotic antiphospholipid syndrome (APS) is long-term anticoagulation with vitamin K antagonists (VKAs) such as warfarin. Non-VKA oral anticoagulants (NOACs), which include rivaroxaban, have been shown to be effective and safe compared warfarin for venous thromboembolism (VTE) in major phase III prospective, randomized controlled trials (RCTs), but results may not directly generalizable patients APS. Aims primary aim demonstrate, APS...

10.1177/0961203315581207 article EN cc-by-nc Lupus 2015-05-04

The COVID-19 pandemic has posed daunting challenges when conducting clinical research. Adopting new technologies such as remote electronic consent (e-Consent) can help overcome them. However, guidelines for e-Consent implementation in ongoing trials are currently lacking. NeuroSAFE PROOF trial is a randomized evaluating the role of frozen section analysis during RARP prostate cancer. In response to crisis, recruitment was halted, and solution designed. aim this paper describe process...

10.1186/s13063-022-06333-6 article EN cc-by Trials 2022-05-12

Crohn's disease (CD) is a lifelong, relapsing and remitting inflammatory condition of the intestine. Medical imaging crucial for diagnosis, phenotyping, activity assessment detecting complications. Diverse small bowel tests are available but standard algorithm deployment lacking. Many hospitals employ that impart ionising radiation, particular concern to this young patient population. Magnetic resonance enterography (MRE) ultrasound (USS) attractive options, as they do not use radiation....

10.1186/1471-230x-14-142 article EN cc-by BMC Gastroenterology 2014-08-11

Abstract Background Previous studies suggest that the beneficial health effects of a diet rich in whole grains could be result individual fibres found grain. The present study aimed to investigate influence high either wheat fibre (as an example insoluble fibre) or inulin (a nondigestible carbohydrate) on markers cardiovascular disease. Methods Ten male participants classified as at higher risk disease [mean (SD) body mass index 30.2 (3) kg m −2 , mean waist circumference 106.4 (7) cm, age...

10.1111/jhn.12251 article EN Journal of Human Nutrition and Dietetics 2014-06-12

The response of the parathyroids to an infusion calcium has been studied in patients with secondary hyperparathyroidism due either vitamin D deficiency or chronic renal failure. Two specific homologous immunoradiometric assays for human parathyroid hormone (PTH) have used assess response, one amino‐terminus (N‐PTH), other carboxy‐terminus (C‐PTH) molecule. In both deficient and uraemic patients, a 4 mg/kg/h generally h, suppression N‐PTH was similar, falling around 20–30% initial value....

10.1111/j.1365-2265.1982.tb02760.x article EN Clinical Endocrinology 1982-05-01

Summary The National Cancer Imaging Translational Accelerator (NCITA) is creating a UK national coordinated infrastructure for accelerated translation of imaging biomarkers clinical use. Through the development standardised protocols, data integration tools and ongoing training programmes, NCITA provides unique scalable biomarker qualification using multicentre studies.

10.1038/s41416-021-01497-5 article EN cc-by British Journal of Cancer 2021-07-27

Abstract Background Robotic radical prostatectomy (RARP) is a first-line curative treatment option for localized prostate cancer. Postoperative erectile dysfunction and urinary incontinence are common associated adverse side effects that can negatively impact patients’ quality of life. Preserving the lateral neurovascular bundles (NS) during RARP improves functional outcomes. However, selecting men NS may be difficult when there concern about incurring in positive surgical margin (PSM) which...

10.1186/s13063-022-06421-7 article EN cc-by Trials 2022-07-22

Skeletal muscle metabolism during exercise was compared in 5 patients with end-stage renal disease (ESRD) and 8 healthy controls, using a noninvasive technique, 31P magnetic resonance spectroscopy (MRS). After 3 months of anaemia correction recombinant human erythropoietin (rHuEPO) these were re-evaluated. Maximal power achieved by the ESRD dynamic wrist flexion test 33% lower (p < 0.05) than controls. Similarly group, at onset metabolic acidosis (the intracellular threshold) 29% less The...

10.1159/000189107 article EN ˜The œNephron journals/Nephron journals 1996-01-01

<h3>Introduction</h3> Circulating prostaglandin E<sub>2</sub> levels are elevated in acutely decompensated cirrhosis and have been shown to contribute immune suppression. Albumin binds inactivates this hormone. Human albumin solution could thus be repurposed as an restorative drug these patients. This feasibility study aims determine whether it is possible safe restore serum &gt;30 g/L maintain at level patients admitted with acute using repeated 20% human infusions according daily levels....

10.1136/bmjopen-2015-010132 article EN cc-by BMJ Open 2016-01-01

Twenty-three patients with end-stage renal failure on maintenance haemodialysis were treated 1, 25-dihydroxy vitamin D3 or 24–25-dihydroxy for 3–32 months (total 232 patient months). Treatment was marked by symptomatic, biochemical and histological improvements in the majority of patients. In constrast, treatment 24, produced no such developed severe symptomatic bone disease. Successful transplantation resulted rapid improvement symptoms, biochemistry histology nine 10 irrespective whether...

10.1093/oxfordjournals.qjmed.a067733 article EN QJM 1982-01-01

A study was conducted evaluating the response of serum parathyroid hormone to acute hypercalcaemia and long term administration 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) in patients receiving maintenance haemodialysis. During infusion elemental calcium 4 mg/kg/h over four hours 12 not vitamin D concentration amino terminal fell by 31-96% (mean 74.8 (SD 17.6)%) while that carboxy changed little. There a strong inverse correlation between baseline percentage fall during (r = 0.88; p less than...

10.1136/bmj.288.6412.177 article EN BMJ 1984-01-21

Validated patient-reported outcome measures (PROMs) have an important role in clinical practice and research studies. The outcomes may be used for patient counselling, clinician decision-making disease or treatment monitoring. Critically, PROMs are comparison of efficacy approaches However, PROMS remain under-utilised research. It is not uncommon studies to clinician-led; thus, prioritisation deemed more the can lead omission PROMS. Further challenges clinicians exist identifying relevant...

10.1002/bco2.136 article EN cc-by BJUI Compass 2022-01-12

An abstract is not available for this content. As you have access to content, full HTML content provided on page. A PDF of also in through the ‘Save PDF’ action button.

10.1017/s0029665108000141 article EN Proceedings of The Nutrition Society 2008-05-01
Coming Soon ...